Literature DB >> 15744579

Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.

Kai Yu Jen1, Masaya Higuchi, Jun Cheng, Jiang Li, Lan Yan Wu, Ying Fang Li, Han Liang Lin, Zhilong Chen, Vladimir Gurtsevitch, Masahiro Fujii, Takashi Saku.   

Abstract

Epstein-Barr virus (EBV) infection is associated with salivary gland lymphoepithelial carcinoma (SLEC) and nasopharyngeal carcinoma (NPC). EBV is a ubiquitous herpes virus world wide, but EBV-associated SLEC and NPC are prevalent in restricted regions such as south areas of China, Southeastern Asia and Greenland (Eskimos). To examine whether particular EBV variants play roles in the development of SLEC and NPC, we isolated the complete EBV LMP1 genes from 12 paraffin-embedded biopsy samples of SLECs isolated from China, Taiwan and Russia, and compared these LMP1 genes with those of NPC (CAO) and the prototype B95-8 EBV. Nucleotide sequence analysis showed that SLECs LMP1 is more similar to that of CAO than that of prototype B95-8. The analysis also identified several conserved (67-100%) variations in SLEC-LMP1 and CAO-LMP1 distinct from B95-8-LMP1. These included 10-amino acid deletion, 5-amino acid deletion and 12-single amino acid variations. A SLEC-LMP1 gene with the aforementioned conserved variations inhibited the growth of an embryonic kidney cell line (293T), highly activated the NF-kappaB pathway, and these activities were equivalent to those of B95-8 and CAO. These findings suggest that the biological functions of SLEC-LMP 1 are similar to those of B95-8-LMP1 and CAO-LMP1, and that these amino acid variations including the well-known 10-aa deletion did not affect these two prominent activities. While the present results could not uncover functional differences between SLEC-LMP1 and B95-8-LMP1, the nucleotide sequences and the molecular clone of LMP1 directly isolated from SLEC patients will be a useful tool to identify the high-pathogenic EBV strain(s), associated with SLEC and NPC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15744579     DOI: 10.1007/s11262-004-5630-5

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  39 in total

1.  The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation.

Authors:  A Kaykas; B Sugden
Journal:  Oncogene       Date:  2000-03-09       Impact factor: 9.867

2.  Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers.

Authors:  N Fischer; B Kopper; N Graf; J R Schlehofer; F A Grässer; N Mueller-Lantzsch
Journal:  Virus Res       Date:  1999-03       Impact factor: 3.303

3.  Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.

Authors:  C W Dawson; A G Eliopoulos; S M Blake; R Barker; L S Young
Journal:  Virology       Date:  2000-06-20       Impact factor: 3.616

4.  Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese.

Authors:  S Y Leung; S T Yuen; L P Chung; A S Chan; M P Wong
Journal:  Int J Cancer       Date:  1997-07-17       Impact factor: 7.396

5.  Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Authors:  K M Kaye; K M Izumi; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

6.  Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.

Authors:  O Devergne; E D Cahir McFarland; G Mosialos; K M Izumi; C F Ware; E Kieff
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma.

Authors:  L Hu; B Troyanovsky; X Zhang; P Trivedi; I Ernberg; G Klein
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

8.  Epstein-Barr virus infected lymphoepithelial carcinomas of the salivary gland in the Russia-Asia area: a clinicopathologic study of 160 cases.

Authors:  Takashi Saku; Jun Cheng; Kai Yu Jen; Masayoshi Tokunaga; Jian Li; Weiguo Zhang; Airu Liu; Lanyan Wu; Yong Lu; Zhiyu Zhou; Yingfang Li; Ruyao Li; Jei Ouyang; Lianjia Yang; Shifeng Yu; Tiecheng Lou; Suozhi Wang; Dyisheng Lin; Huilan Rao; Hanliang Lin; Patima Sderk; Zhaolun Chen; Zhirong Chen; Chonghong Cai; Hyunjung Kim; Sanpyo Hong
Journal:  Arkh Patol       Date:  2003 Mar-Apr

9.  All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

Authors:  R K Moorthy; D A Thorley-Lawson
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation.

Authors:  Weigang Tang; Oleg A Pavlish; Vladimir S Spiegelman; Andrey A Parkhitko; Serge Y Fuchs
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

View more
  5 in total

1.  Epstein-Barr virus-associated lymphoepithelial carcinoma after pediatric liver transplant.

Authors:  Adam X Sang; Aleishia Harris-Arnold; Neeraja Kambham; Olivia M Martinez; Sheri M Krams; Debra Strichartz; Carlos O Esquivel
Journal:  Liver Transpl       Date:  2016-06       Impact factor: 5.799

2.  Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States.

Authors:  Fatma M Shebl; Kishor Bhatia; Eric A Engels
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

3.  Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation.

Authors:  Emilie Zuercher; Christophe Butticaz; Josiane Wyniger; Raquel Martinez; Manuel Battegay; Emmanuelle Boffi El Amari; Thanh Dang; Jean-François Egger; Jan Fehr; Esther Mueller-Garamvögyi; Andrea Parini; Stephan C Schaefer; Franziska Schoeni-Affolter; Christine Thurnheer; Marianne Tinguely; Amalio Telenti; Sylvia Rothenberger
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 4.  Epstein-barr virus sequence variation-biology and disease.

Authors:  Stelios Tzellos; Paul J Farrell
Journal:  Pathogens       Date:  2012-11-08

5.  HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.

Authors:  Yang Lifang; Tang Min; Ai Midan; Cao Ya
Journal:  J Exp Clin Cancer Res       Date:  2008-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.